PDHA2: A Drug Target and Biomarker for Various Diseases (G5161)

Target Name: PDHA2

NCBI ID: G5161

PDHA2

PDHA2: A Drug Target and Biomarker for Various Diseases

PDHA2 (poly(D,A)nitrile), also known as PDP, is a drug target and a biomarker that is involved in the development and progression of various diseases, including cancer. It is a transmembrane protein that is expressed in various tissues and cells in the body.

PDHA2 is a key regulator of the cell-cell adhesion process, which is critical for the development and maintenance of tissues and organs. It plays a vital role in the regulation of cell proliferation, differentiation, and adhesion, as well as in the regulation of cell survival.

PDHA2 is also involved in the regulation of cell signaling pathways, including the TGF-β pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival, and is a key factor in the development and progression of many diseases, including cancer.

PDHA2 is a good candidate for drug targeting because of its involvement in the regulation of cell signaling pathways and its role in the development and progression of various diseases. It is also a potential biomarker for the diagnosis and treatment of these diseases.

One of the main challenges in the development of new drugs is the difficulty of predicting the exact mechanism of action of a drug. This is because drugs can act on multiple targets, making it difficult to determine exactly how and where the drug works. PDHA2 is one of

Protein Name: Pyruvate Dehydrogenase E1 Subunit Alpha 2

Functions: The pyruvate dehydrogenase complex catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2), and thereby links the glycolytic pathway to the tricarboxylic cycle

The "PDHA2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PDHA2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets